Skip to main content

Owen Mumford and NIPRO have signed an exclusive agreement to distribute UniSafe throughout Japan

Oxford, July 8, 2019 – Owen Mumford, a global leader in medical devices, is pleased to announce it has signed an exclusive agreement with Osaka-based NIPRO CORPORATION.

JULY 2019
Share the article
latest-news-nipro

The agreement allows UniSafe to be distributed, supporting the increased focus on safety in Japan’s innovative and established healthcare market.

  • Partnerships are key to international business success. Owen Mumford and Nipro share a foundation of quality and innovation and a joint vision for collaboration.
  • UniSafe is a one-of-a-kind, springless, passive safety device for 1mL pre-filled syringes. It brings cutting-edge technology and innovation to Japan, supporting safety and confidence in self-injection. (A platform based on UniSafe is in development, including the UniSafe 2.25mL device).
  • UniSafe has received regulatory approval in the EU for commercial launch, and more than 20 Global Pharma companies are currently evaluating it for product launches.

UniSafe is a unique, springless, passive safety device for 1mL pre-filled syringes, specifically developed to address challenges with traditional spring-based safety systems. Because there is no spring, UniSafe is reliable, intuitive, and simple to use. The secure plunger design helps prevent both reuse and accidental removal.

Jarl Severn, CEO at Owen Mumford, stated, “It’s clear that healthcare in Japan is experiencing strong growth, so it is essential for us to partner with companies that share our commitment to delivering innovative solutions in this market. This is a major partnership for Owen Mumford and helps support our goals for global expansion.”

Tsuyoshi Yamazaki, Managing Director of the PharmaPackaging Division at Nipro Corporation, stated, “We are pleased to add UniSafe to our lineup of innovative safety solutions and to contribute to the Japanese healthcare market. We believe this partnership with Owen Mumford, a pioneer in new devices, will support the development and sales of Nipro’s reconstitution and administration devices.”

The agreement became effective in April 2019, and both companies look forward to a strong, lasting partnership.

For more information about UniSafe, please contact the Nipro PharmaPackaging Division (e-mail: pharmapackaging-japan@nipro.co.jp) or Owen Mumford (e-mail: devicesolutions@owenmumford.com)

Get in touch

* Field is required.